End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
49.3 CNY | +2.69% | +8.45% | -33.84% |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
Apr. 22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 6185 Stock
- 688185 Stock
- News CanSino Biologics Inc.
- Market Chatter: CanSino's COVID-19 Vaccine Achieves 65.7% Efficacy Rate for Symptomatic Cases